Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)

Clinical trial NCT06534463 · RECRUITING

Trial details

NCT number: NCT06534463
Sponsor: Ruijin Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Marginal Zone Lymphoma

Start date: 2024-08-02
Primary completion: 2029-03-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.